ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 992,87
0,18%
Dow Jones
38 686,32
1,51%
DAX
18 497,94
-0,09%
Brent Oil
81,295
0,00%
Bitcoin
67 699,97
0,32%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Delcath Systems Inc (DCTH)

  7. Delcath Systems Inc (DCTH) Actualités

DCTH

Delcath Systems (DCTH)

Delcath Systems Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:DCTH
DateHeureSourceTitreSymboleSociété
29/05/202422h06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DCTHDelcath Systems Inc
28/05/202422h32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DCTHDelcath Systems Inc
28/05/202415h30Business WireDelcath Systems Announces Appointment of Bridget Martell, MA, MD to Delcath’s Board of DirectorsNASDAQ:DCTHDelcath Systems Inc
17/05/202418h48Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:DCTHDelcath Systems Inc
16/05/202420h05Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:DCTHDelcath Systems Inc
14/05/202415h14Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DCTHDelcath Systems Inc
14/05/202413h30PR Newswire (US)Delcath Systems Reports First Quarter 2024 Results and Business HighlightsNASDAQ:DCTHDelcath Systems Inc
10/05/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:DCTHDelcath Systems Inc
09/05/202423h12Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:DCTHDelcath Systems Inc
08/05/202422h02Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:DCTHDelcath Systems Inc
07/05/202414h30PR Newswire (US)Delcath Systems to Host First Quarter 2024 Earnings CallNASDAQ:DCTHDelcath Systems Inc
06/05/202415h00PR Newswire (US)Publication of Results from Pivotal FOCUS Study in Metastatic Uveal Melanoma Patients treated with HEPZATO KITNASDAQ:DCTHDelcath Systems Inc
03/05/202423h15PR Newswire (US)Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:DCTHDelcath Systems Inc
04/04/202414h35PR Newswire (US)Delcath Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:DCTHDelcath Systems Inc
26/03/202412h30PR Newswire (US)Delcath Systems Reports Fourth Quarter and Full Year 2023 Results and Provides Business UpdateNASDAQ:DCTHDelcath Systems Inc
20/03/202413h15PR Newswire (US)Delcath Systems Closes $7 Million Private PlacementNASDAQ:DCTHDelcath Systems Inc
19/03/202414h00PR Newswire (US)Delcath Systems to Host Fourth Quarter and Full Year 2023 Results and Business Update CallNASDAQ:DCTHDelcath Systems Inc
18/03/202422h20PR Newswire (US)Delcath Systems Appoints Martha S. Rook as Chief Operating OfficerNASDAQ:DCTHDelcath Systems Inc
15/03/202413h20PR Newswire (US)Delcath Systems Announces $7 Million Private PlacementNASDAQ:DCTHDelcath Systems Inc
08/03/202415h00PR Newswire (US)Delcath Systems to Participate in Upcoming Investor ConferencesNASDAQ:DCTHDelcath Systems Inc
22/02/202423h00PR Newswire (US)Delcath Systems Announces Healthcare Setting Locator for HEPZATO™ KIT (melphalan/Hepatic Delivery System)NASDAQ:DCTHDelcath Systems Inc
14/02/202416h08Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:DCTHDelcath Systems Inc
31/01/202414h00PR Newswire (US)Delcath Systems Receives Permanent J-Code (J9248) for HEPZATO™ (melphalan/Hepatic Delivery System) Effective April 1, 2024NASDAQ:DCTHDelcath Systems Inc
23/01/202414h00PR Newswire (US)Delcath Systems to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select ConferenceNASDAQ:DCTHDelcath Systems Inc
16/01/202414h00PR Newswire (US)Delcath Systems Announces U.S. Launch and First Commercial Treatment Utilizing HEPZATO KIT™NASDAQ:DCTHDelcath Systems Inc
09/01/202414h12Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:DCTHDelcath Systems Inc
15/12/202323h22Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:DCTHDelcath Systems Inc
07/12/202315h00PR Newswire (US)Delcath Systems Announces Publication by Independent Investigators of a Retrospective Analysis of Quality of Life in the Journal Melanoma ResearchNASDAQ:DCTHDelcath Systems Inc
15/11/202323h00PR Newswire (US)Delcath Systems Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:DCTHDelcath Systems Inc
13/11/202322h05PR Newswire (US)Delcath Systems Reports Third Quarter 2023 Results and Provides Business UpdateNASDAQ:DCTHDelcath Systems Inc
 Showing the most relevant articles for your search:NASDAQ:DCTH

Dernières Valeurs Consultées

ASX
FXPKOC
COIN
LMFIUSD
COIN
HALVBTC
EU
IRISU
Iris Financial
LSE
GXLK
Spdr $ Tech
LSE
60EW
Investec Bnk 26
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés